Published in J Psychiatr Res on February 01, 1970
Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry (2010) 1.00
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82
Interacting mechanisms of impulsivity in bipolar disorder and antisocial personality disorder. J Psychiatr Res (2011) 0.77
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Biogenic amines and emotion. Science (1967) 3.49
The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry (1998) 3.26
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry (1990) 2.22
Supplemental social services improve outcomes in public addiction treatment. Addiction (1998) 2.21
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom (1995) 1.92
Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry (1999) 1.87
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochem Pharmacol (1968) 1.64
Acetylcholine stimulation of the phosphodiesteratic cleavage of guinea pig brain phosphoinositides. Life Sci (1968) 1.58
Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry (1996) 1.56
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
The enzymic hydrolysis of phosphatidyl inositol by guinea pig brain: Sub-cellular distribution and hydrolysis products. J Neurochem (1969) 1.49
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry (1997) 1.47
Bowel obsessions responsive to tricyclic antidepressants in four patients. Am J Psychiatry (1987) 1.44
Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry (1989) 1.44
Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch Gen Psychiatry (1991) 1.44
The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest (1970) 1.42
Does clinical case management improve outpatient addiction treatment. Drug Alcohol Depend (1999) 1.39
Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics (2000) 1.32
Acetylcholine action: biochemical aspects. Science (1969) 1.32
Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc (2000) 1.30
Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat (1993) 1.25
The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychother Psychosom (2000) 1.23
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (2000) 1.22
Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry (1999) 1.22
Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry (1973) 1.21
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
Intravascular clotting and acute pancreatitis in primary hyperparathyroidism. Ann Intern Med (1966) 1.21
A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry (1995) 1.20
Hypertension is associated with severe erectile dysfunction. J Urol (2000) 1.19
The Massachusetts General Hospital (MGH) Hairpulling Scale: 2. reliability and validity. Psychother Psychosom (1995) 1.16
Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand (1997) 1.15
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
Mechanisms of renal lithium handling and their relationship to mineralocorticoids: a dissociation between sodium and lithium ions. J Psychiatr Res (1971) 1.14
Acetylcholine-stimulated phosphodiesteratic cleavage of phosphoinositides: hypothetical role in membrane depolarization. Ann N Y Acad Sci (1969) 1.13
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
The relation of contractile enhancement to action potential change in canine myocardium. Circ Res (1967) 1.11
Statistical problems with small sample size. Am J Psychiatry (1993) 1.10
Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington. Eval Rev (2000) 1.10
Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry (1997) 1.09
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacol Bull (1974) 1.06
Simultaneous assay by mass fragmentography of vanillyl mandelic acid, homovanillic acid, and 3-methoxy-4-hydroxy-phenethylene glycol in cerebrospinal fluid and urine. Biochem Med (1974) 1.05
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Am J Cardiol (1973) 1.05
Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am J Med (1973) 1.05
Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology (2000) 1.04
Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry (1997) 1.03
Cardiac failure in Addison's disease. Am J Med (1983) 1.03
The Skin Picking Scale: scale construction and psychometric analyses. J Psychosom Res (2001) 1.03
The role of inotropic variation in ventricular function during atrial fibrillation. J Clin Invest (1970) 1.02
Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (1995) 1.02
Self-administered psychotherapy for depression using a telephone-accessed computer system plus booklets: an open U.S.-U.K. study. J Clin Psychiatry (1998) 1.01
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am J Psychiatry (1973) 0.99
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology (1970) 0.98
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry (2001) 0.97
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. Am J Med (1975) 0.97
Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology (1996) 0.97
Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis (1998) 0.97
Normetanephrine excretion and affective state in depressed patients treated with imipramine. Am J Psychiatry (1966) 0.97
A stressful social situation as a precipitant of schizophrenic symptoms: an epidemiological study. Br J Psychiatry (1968) 0.96
A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics (1990) 0.96
Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry (1972) 0.96
History of suicidal behavior in depressed borderline inpatients. Am J Psychiatry (1983) 0.95
Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry (2001) 0.94
Applicability of telemedicine for assessing patients with schizophrenia: acceptance and reliability. J Clin Psychiatry (1997) 0.94
Setters and samoyeds: the emergence of subordinate level categories as a basis for inductive inference in preschool-age children. Dev Psychol (1997) 0.94
Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther (1996) 0.94
Potassium and the monophasic action potential, electrocardiogram, conduction and arrhythmias. Prog Cardiovasc Dis (1966) 0.94
Studies on the acetylcholine-stimulated incorporation of radioactive inorganic orthophosphate into the phospholipid of brain particulate preparations. II. Subcellular distribution of enzymic activity. J Neurochem (1966) 0.94
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid. J Neurochem (1973) 0.93
Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med (1985) 0.93
Lithium-induced changes in electrolyte balance and tissue electrolyte concentration. Psychopharmacologia (1970) 0.93
The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Psychopharmacologia (1971) 0.93
Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res (1970) 0.93
Intracellular electrophysiological alterations in canine cardiac conducting tissue induced by aprindine and lignocaine. Cardiovasc Res (1976) 0.93
Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology (Berl) (1981) 0.92
3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid. Clin Chim Acta (1971) 0.92
Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. Int J Impot Res (2001) 0.92
Development and initial validation of a brief mental health outcome measure. J Pers Assess (1999) 0.92
Tranylcypromine: effects on norepinephrine metabolism in rat brain. Am J Psychiatry (1970) 0.91
Effects of cycle-length alteration on canine cardiac action potentials. Am J Physiol (1967) 0.91
Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. Am J Psychiatry (1967) 0.91
Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg (2000) 0.91
Can patients with obsessive-compulsive disorder discriminate between percepts and mental images? A signal detection analysis. J Abnorm Psychol (1994) 0.91
"Intensive" outpatient substance abuse treatment: comparisons with "traditional" outpatient treatment. J Addict Dis (1997) 0.90
Asynchrony of conduction within the canine specialized Purkinje fiber system. Circ Res (1970) 0.90
Renin and aldosterone suppression in the antihypertensive action of clonidine. Am J Cardiol (1976) 0.89
Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology (1988) 0.89
Role of the premature action potential in contractile potentiation: a study of paired stimulation. Cardiovasc Res (1972) 0.89
Recall and recognition memory in obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci (1996) 0.89